BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37253458)

  • 1. Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
    Kim JH; Lee JY; Yu SJ; Lee DH; Joo I; Yoon JH; Kim YJ; Yoon JH; Lee JM
    Int J Hyperthermia; 2023; 40(1):2213424. PubMed ID: 37253458
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.
    Han S; Lee JM; Lee DH; Yoon JH; Chang W
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1579-1596. PubMed ID: 34312690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ultrasound-guided thermal ablation for liver tumor with artificial pleural effusion or ascites.
    Liu LN; Xu HX; Lu MD; Xie XY
    Chin J Cancer; 2010 Sep; 29(9):830-5. PubMed ID: 20800026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations.
    Hsieh YC; Limquiaco JL; Lin CC; Chen WT; Lin SM
    Abdom Radiol (NY); 2019 Mar; 44(3):1141-1151. PubMed ID: 30460530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Clin Radiol; 2013 Dec; 68(12):e641-51. PubMed ID: 23973161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.
    Uehara T; Hirooka M; Ishida K; Hiraoka A; Kumagi T; Kisaka Y; Hiasa Y; Onji M
    J Gastroenterol; 2007 Apr; 42(4):306-11. PubMed ID: 17464460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
    Lee Y; Yoon JH; Han S; Joo I; Lee JM
    Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
    Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
    Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome.
    Iwai S; Sakaguchi H; Fujii H; Kobayashi S; Morikawa H; Enomoto M; Tamori A; Kawada N
    Hepatogastroenterology; 2012; 59(114):546-50. PubMed ID: 22353522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers.
    Han K; Kim JH; Kim GH; Kim JH; Kim SY; Park SH; Moon S; Kwon JH; Kim GM; Lee SJ; Won HJ; Shin YM
    Eur Radiol; 2024 Mar; 34(3):1578-1586. PubMed ID: 37646813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
    Rhim H; Lim HK; Kim YS; Choi D
    AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors.
    Wang Y; Zhang L; Li Y; Wang W
    Int J Hyperthermia; 2020; 37(1):256-262. PubMed ID: 32157926
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.
    Song I; Rhim H; Lim HK; Kim YS; Choi D
    Eur Radiol; 2009 Nov; 19(11):2630-40. PubMed ID: 19557416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm.
    Koda M; Ueki M; Maeda Y; Mimura K; Okamoto K; Matsunaga Y; Kawakami M; Hosho K; Murawaki Y
    AJR Am J Roentgenol; 2004 Sep; 183(3):583-8. PubMed ID: 15333339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study.
    Choi TW; Lee JM; Lee DH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Han JK
    Korean J Radiol; 2017; 18(5):799-808. PubMed ID: 28860897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.